Half-year report · Q2
3937.TEDINET S100UMD4
Period2024-04-01 → 2024-09-30
Filed2024-11-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥5.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥591m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥541m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥629m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥936m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥467m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥629m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥467m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥443m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥526m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥301m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥443m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥301m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥7.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥6.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥6.4bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.1bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥2.2bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.4bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.6bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.8bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥651m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥727m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥504m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥39m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥273m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥221m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥57m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥155m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥169m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥36.87 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.73 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.57 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.81 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.15 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.1 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 70.5% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥22m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥190m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.3bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥15m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥240m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥847m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥841m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥542m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.1bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥22m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥781m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥781m |
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥600,000 |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥600,000 |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥300,000 |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥17m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥17m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥170m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E32408-000Globalreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| jpcrp040300-q2r_E32408-000Globalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥233m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥798m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥798m |
| jpcrp040300-q2r_E32408-000Medicalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥477m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥711m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥17m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥711m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 495
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase in short term loans payable fin cf | Prior1YTDDuration | 100000000 | JPY |
| Increase in short term loans payable fin cf | CurrentYTDDuration | 100000000 | JPY |
| Decrease in short term loans payable fin cf | Prior1YTDDuration | -100000000 | JPY |
| Decrease in short term loans payable fin cf | CurrentYTDDuration | -100000000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | Prior1YTDDuration | 9752000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYTDDuration | 162722000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -56000 | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -49121000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -65481000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -129167000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -153862000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -168537000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -56678000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 78966000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -18971000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 193447000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 536750000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 3636780000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 4026101000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 3830227000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 4562851000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 156462000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 157254000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 18998000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 21015000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 7020000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 17612000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -5116000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -769000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember | 2131088000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember | 798236000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 2929325000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OtherReportableSegmentsMember | 600000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2929925000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 2929925000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember | 17491000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 17491000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OtherReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 17491000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -17491000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember | 2148579000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember | 798236000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 2946816000 | JPY |
| Net sales | Prior1YTDDuration_OtherReportableSegmentsMember | 600000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2947416000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -17491000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |